Marker Therapeutics, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US57055L2060
USD
1.66
-0.06 (-3.49%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1248920,
    "name": "Marker Therapeutics, Inc.",
    "stock_name": "Marker Therapeutics, Inc.",
    "full_name": "Marker Therapeutics, Inc.",
    "name_url": "stocks-analysis/marker-therapeutics-inc",
    "exchange": 1,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "1.66",
    "chg": -0.06,
    "chgp": "-3.49%",
    "dir": -1,
    "prev_price": "1.72",
    "mcapval": "36.51",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2320,
    "indexname": "S&P 500",
    "isin": "US57055L2060",
    "curr_date": "Feb 05",
    "curr_time": "",
    "bse_nse_vol": "454.9 k",
    "exc_status": "Active",
    "traded_date": "Feb 05, 2026",
    "traded_date_str": "2026 02 05",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/marker-therapeutics-inc-1248920-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Marker Therapeutics Experiences Revision in Its Stock Evaluation Amid Financial Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/marker-therapeutics-inc-financial-trend-shifts-from-negative-to-flat-despite-declining-sales-3718582",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/MarkerTherapeut_fintrenddot_3718582.png",
        "date": "2025-11-20 15:40:01",
        "description": "Marker Therapeutics, Inc. reported a challenging quarter ending June 2025, with significant declines in net sales and critical financial metrics. Despite achieving its highest operating cash flow, the company struggles with low net sales and negative returns, contrasting sharply with broader market performance."
      }
    ],
    "total": 8,
    "sid": "1248920",
    "stock_news_url": "https://www.marketsmojo.com/news/marker-therapeutics-inc-1248920"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}
stock-recommendationAnnouncement
Icon
No announcement available
stock-recommendationCorporate Actions
Corporate Actions
info
Icon
No corporate action available